Levels Diagnostics
PrivateLast Round
Pre Seed
Dec 6, 2023
Total Funding Raised
$550,000
Company Overview
Levels Diagnostics operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Pre Seed round in December 2023.
Levels Diagnostics is a biotechnology company that develops diagnostic tools specializing in biomarker discovery and clinical studies for infectious diseases as well as liver and kidney diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Levels Diagnostics Comparables
Compare Levels Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Visby Medical | 79% | |
| Inflammatix | 78% | |
| Thrixen | 78% |
For institutional investors. Book with your work email.
Levels Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 6, 2023 | ||||
| Accelerator | Jul 7, 2022 | ||||
| Grant | Jan 18, 2021 | ||||
| Grant | Aug 1, 2020 | ||||
| Grant | Jun 1, 2020 | ||||
Grant | Oct 1, 2019 |
For institutional investors. Book with your work email.
Levels Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| imec.istart | Accelerator |
| Libertatis Ergo Holding | Pre Seed |
| European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie) | Grant |
| Provincie Zuid-Holland | Grant |
| EU Eureka Innowwide | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 6, 2023
$410K round led by Libertatis Ergo Holding
- Jan 18, 2021
Received grant funding from Provincie Zuid-Holland.
For institutional investors. Book with your work email.
Levels Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Levels Diagnostics's valuation, stock price, and market status.
Is Levels Diagnostics a public or private company?
Levels Diagnostics is a private company.
What is the current stock price of Levels Diagnostics?
Levels Diagnostics is a private company, so its shares have no public market price. Caplight tracks Levels Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Levels Diagnostics worth (valuation)?
Valuation information for Levels Diagnostics is not publicly available.
Can I buy Levels Diagnostics stock?
Levels Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Levels Diagnostics's last funding round?
Levels Diagnostics's most recent funding round was Pre Seed on December 6, 2023.
Who are the main investors in Levels Diagnostics?
Key investors in Levels Diagnostics include Libertatis Ergo Holding.
Will Levels Diagnostics IPO soon?
No public IPO plans have been announced for Levels Diagnostics.
How can I track Levels Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Levels Diagnostics's shares on secondary markets.